Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
activist investor
Pharma
Turbulent times at Aurinia with renewed investor activism
Four Aurinia board directors—including CEO Peter Greenleaf—and the proposed exec compensation recently failed to win majority shareholder support.
Angus Liu
Aug 13, 2024 11:30am
Novavax investor Shah Capital jabs at vaccine maker
Apr 15, 2024 10:48am
Bayer taps activist investor Jeffrey Ubben for board seat
Mar 1, 2024 12:03pm
Activist investor Elliott takes $1B stake in BioMarin: report
Nov 8, 2023 8:25am
Aurinia quells investor unrest, names former CEO Foster to board
Sep 21, 2023 10:55am
Catalent turns to Elliott after 2023 earnings disappoint
Aug 30, 2023 9:41am
